Literature DB >> 11000227

Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis.

G J Poggioli1, C Keefer, J L Connolly, T S Dermody, K L Tyler.   

Abstract

Serotype-specific differences in the capacity of reovirus strains to inhibit proliferation of murine L929 cells correlate with the capacity to induce apoptosis. The prototype serotype 3 reovirus strains Abney (T3A) and Dearing (T3D) inhibit cellular proliferation and induce apoptosis to a greater extent than the prototype serotype 1 reovirus strain Lang (T1L). We now show that reovirus-induced inhibition of cellular proliferation results from a G(2)/M cell cycle arrest. Using T1L x T3D reassortant viruses, we found that strain-specific differences in the capacity to induce G(2)/M arrest, like the differences in the capacity to induce apoptosis, are determined by the viral S1 gene. The S1 gene is bicistronic, encoding the viral attachment protein sigma1 and the nonstructural protein sigma1s. A sigma1s-deficient reovirus strain, T3C84-MA, fails to induce G(2)/M arrest, yet retains the capacity to induce apoptosis, indicating that sigma1s is required for reovirus-induced G(2)/M arrest. Expression of sigma1s in C127 cells increases the percentage of cells in the G(2)/M phase of the cell cycle, supporting a role for this protein in reovirus-induced G(2)/M arrest. Inhibition of reovirus-induced apoptosis failed to prevent virus-induced G(2)/M arrest, indicating that G(2)/M arrest is not the result of apoptosis related DNA damage and suggests that these two processes occur through distinct pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000227      PMCID: PMC112387          DOI: 10.1128/jvi.74.20.9562-9570.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Differential sensitivity of normal and transformed human cells to reovirus infection.

Authors:  M R Duncan; S M Stanish; D C Cox
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

2.  Molecular basis of viral neurotropism: experimental reovirus infection.

Authors:  K L Tyler; R T Bronson; K B Byers; B Fields
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

3.  Initiation of DNA replication in mammalian cells and its inhibition by reovirus infection.

Authors:  R Hand; I Tamm
Journal:  J Mol Biol       Date:  1974-01-15       Impact factor: 5.469

4.  Cellular DNA replication in infections with cytocidal RNA viruses.

Authors:  R Hand; W D Ensminger; I Tamm
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

5.  Inhibition of the initiation of cellular DNA synthesis after reovirus infection.

Authors:  D C Cox; J E Shaw
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

6.  The step in cellular DNA synthesis blocked by reovirus infection.

Authors:  W D Ensminger; I Tamm
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

7.  Reovirus inhibition of cellular DNA synthesis: role of the S1 gene.

Authors:  A H Sharpe; B N Fields
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

8.  Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames.

Authors:  H Ernst; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  Cellular integrity is required for inhibition of initiation of cellular DNA synthesis by reovirus type 3.

Authors:  M R Roner; D C Cox
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  44 in total

1.  Novel nuclear herniations induced by nuclear localization of a viral protein.

Authors:  Cristen C Hoyt; Ron J Bouchard; Kenneth L Tyler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.

Authors:  Maya Shmulevitz; Shashi A Gujar; Dae-Gyun Ahn; Adil Mohamed; Patrick W K Lee
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 4.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

5.  Sequential partially overlapping gene arrangement in the tricistronic S1 genome segments of avian reovirus and Nelson Bay reovirus: implications for translation initiation.

Authors:  Maya Shmulevitz; Zareen Yameen; Sandra Dawe; Jingyun Shou; David O'Hara; Ian Holmes; Roy Duncan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike.

Authors:  D J M van den Wollenberg; I J C Dautzenberg; W Ros; A D Lipińska; S K van den Hengel; R C Hoeben
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

7.  Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors.

Authors:  Sarah M Richardson-Burns; Douglas J Kominsky; Kenneth L Tyler
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

8.  Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase.

Authors:  J David Beckham; Robin J Goody; Penny Clarke; Christophe Bonny; Kenneth L Tyler
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Experimental reovirus-induced acute flaccid paralysis and spinal motor neuron cell death.

Authors:  Robin J Goody; Stephanie A Schittone; Kenneth L Tyler
Journal:  J Neuropathol Exp Neurol       Date:  2008-03       Impact factor: 3.685

10.  Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.

Authors:  Shizuko Sei; Jodie K Mussio; Quan-en Yang; Kunio Nagashima; Ralph E Parchment; Matthew C Coffey; Robert H Shoemaker; Joseph E Tomaszewski
Journal:  Mol Cancer       Date:  2009-07-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.